Sotagliflozin in combination with optimised insulin therapy reduced HbA(1c) levels with a decreased daily insulin requirement after 52 weeks in adults with type 1 diabetes-MedSci.cn

Sotagliflozin in combination with optimised insulin therapy reduced HbA(1c) levels with a decreased daily insulin requirement after 52 weeks in adults with type 1 diabetes

Pettus, J; Weinzimer, S; McCrimmon, R; Ampudia-Blasco, F; Stewart, J; Strumph, P; Oliveira, J; Lapuerta, P; Castro, R

DIABETOLOGIA, 2018; 61 (): S295

科室
- - 订阅+
  - 更多科室
工具
服务